인바이오

352940KOSDAQ

47.5 / 100

Reference Date: 2026-10-23

Financial Score23.0 / 40

News Sentiment12.5 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 15.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Inbio produces and sells multifunctional pesticides, herbicides, and eco-friendly crop protection products, developing combined formulations to reduce farmers' workload and increase agricultural income. Responding to rising demand for labor-saving combined products, the company invests in R&D to differentiate its offerings through enhanced efficacy and user convenience, driving market growth.

Number of Employees

158people

Average Salary

44.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

20.65Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.49Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

2.41Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

12.23Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲0.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲53.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.5% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 1,920Won52-week high 2,41052-week low 1,920

1-month return0.0Point

1m -15.23% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-22
Neutral주식등의대량보유상황보고서(약식)2026-10-13
Neutral증권발행결과(자율공시)2026-10-12
Neutral주요사항보고서(전환사채권발행결정)2026-10-02
Neutral독립이사의선임ㆍ해임또는중도퇴임에관한신고2026-10-01